About Us

ConSynance Therapeutics is an emerging innovative drug discovery company based in Albany, New York. With our passion for drug R&D, proven track records, nimble business model and industrial connections both in the US and globally, we believe that we can efficiently and creatively advance new drug candidates for partnering and commercialization.

We have assembled a pipeline of several preclinical and early development programs in metabolic, autoimmune, digestive and CNS disease areas since launching the company in 2014. Through strategic collaborations we will deliver differentiated, first-in-class therapeutics to address important medical needs.